The Age-Related Macular Degeneration Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for age-related macular degeneration has seen robust growth in the past. The market value, which was $9.96 billion in 2024, is projected to increase to $10.7 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.5%.
The Age-Related Macular Degeneration Global Market is projected to reach a size of $14.38 billion in 2029, with a forecasted compound annual growth rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 Age-Related Macular Degeneration Market Report and Uncover Key Trends Now!The key drivers in the age-related macular degeneration market are:
• Expansion in research areas of genetics and biomarkers
• Advancement and adoption of telemedicine and remote monitoring
• Improvement in patient advocacy and comprehensive education about the disease
• Continuous development in personalized medicine approaches and innovative retinal imaging technologies
The age-related macular degeneration market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Products
3) By Route Of Administration: Intravenous, Intravitreal
4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy
The key trends in the age-related macular degeneration market are:
• Personalized medicine approaches are emerging as a leading trend in the market.
• There is increased innovation in retinal imaging technologies.
• The market is witnessing the emergence of sustained drug delivery systems.
• Increased clinical trials for investigational therapies and collaborative R&D stand out as an upcoming trend.
The major players in the age-related macular degeneration market are:
• F.Hoffmann-La Roche AG
North America was the largest region in the global age-related macular degeneration market in 2024